Possible risk of skin reaction with DPP-4 inhibitors

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-018-41640-x
中图分类号
学科分类号
摘要
引用
收藏
页码:5 / 5
相关论文
共 50 条
  • [32] DPP-4 inhibitors and the relations between rosiglitazone and the risk of myocardial infarction
    Lee, Hyoung Woo
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2008, 51 (04): : 371 - 376
  • [33] The efficacy and safety of DPP-4 inhibitors considering cardiovascular risk factors
    Szymborska-Kajanek, Aleksandra
    Wrobel, Marta
    Rokicka, Dominika
    Bozek, Anna
    Strojek, Krzysztof
    CLINICAL DIABETOLOGY, 2013, 2 (06): : 220 - 225
  • [34] Cardiovascular risk with DPP-4 inhibitors: latest evidence and clinical implications
    Karagiannis, Thomas
    Bekiari, Eleni
    Boura, Panagiota
    Tsapas, Apostolos
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2016, 7 (02) : 36 - 38
  • [35] DPP-4 Inhibitors Impact on glycemic control and cardiovascular risk factors
    Dicker, Dror
    DIABETES CARE, 2011, 34 : S276 - S278
  • [36] Pancreatitis or Pancreatic Cancer with DPP-4 Inhibitors
    不详
    PHARMACEUTICAL MEDICINE, 2019, 33 (06) : 540 - 540
  • [37] The effects of DPP-4 inhibitors in human macrophages
    Benetti, E.
    Bordano, V.
    Boscaro, V.
    Cannito, S.
    Altamura, V.
    Barberis, M.
    Rosa, A.
    Bocca, C.
    Klein, T.
    Dianzani, C.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S276 - S277
  • [38] An assessment of the potential toxicity of DPP-4 Inhibitors
    Russell, Jason L.
    Casavant, Marcel J.
    Spiller, Henry A.
    Mercurio-Zappala, Maria
    Huffman, R. Michelle
    CLINICAL TOXICOLOGY, 2013, 51 (07) : 657 - 657
  • [39] Efficacy and Cardiovascular Safety of DPP-4 Inhibitors
    Subrahmanyan, Nikhila A.
    Koshy, Rithika M.
    Jacob, Koshy
    Pappachan, Joseph M.
    CURRENT DRUG SAFETY, 2021, 16 (02) : 154 - 164
  • [40] DPP-4 Inhibitors: The Seinfeld of Oral Antihyperglycemics
    Barry, Arden R.
    Turgeon, Ricky D.
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2016, 69 (03): : 253 - 254